Structural studies of shikimate 5-dehydrogenase from Mycobacterium tuberculosis

Proteins: Structure, Function and Genetics

Volumn 72, Issue 2, 2008, Pages 720-730

  Arcuri, Helen A ^a   Borges, Júlio C ^a,c   Fonseca, Isabel O ^b   Pereira, José H ^a   Neto, João Ruggiero ^a   Basso, Luiz A ^b   Santos, Diógenes S ^b   De Azevedo Jr , Walter F ^b,c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Circular dichroism; Modeling; Mycobacterium tuberculosis; Shikimate pathway

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDOREDUCTASE; SHIKIMATE DEHYDROGENASE;

AMINO ACID SEQUENCE; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; ENZYME ANALYSIS; ENZYME BINDING; ENZYME STABILITY; ENZYME STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

ALCOHOL OXIDOREDUCTASES; AMINO ACID SEQUENCE; CIRCULAR DICHROISM; DIMERIZATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; NADP; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

ALGAE; BACTERIA (MICROORGANISMS); EMBRYOPHYTA; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; MAMMALIA; MYCOBACTERIUM TUBERCULOSIS;

EID: 46449088822     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21953     Document Type: Article

References (52)

1. WHO. WHO report, WHO/CDS/TB/2004.331. Geneva, Switzerland: World Health Organization; 2004.
2. Duncan K. Identification and validation of novel drug targets in tuberculosis. Curr Pharm Des 2004;10:3185-3194.
3. Dye C. Global epidemiology of tuberculosis. Lancet 2006;367:938-940.
4. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1998;257:1055-1064.
5. CDC (Centers for Disease Control and Prevention). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-305.
6. Singh JA, Upshurs R, Padayatchi N. XDR-TB in South Africa: no time for denial or complacency. PLoS Med 2007;4:e50.
7. Davies GM, Barret-Bee KJ, Jude DA, Lehan M, Nichols WW, Pinder PE, Thain JL, Watkins WJ, Wilson RG. (6S)-6-fluoroshikimic acid, an antibacterial agent acting on the aromatic biosynthetic pathway. Antimicrob Agents Chemother 1994;38:403-406.
8. Coggins JR. The shikimate pathway as a target for herbicides. In: Dodge A, editor. Herbicides and plant metabolism. Cambridge, UK: Cambridge University Press; 1989. pp 97-112.
9. Bentley R. The shikimate pathway - metabolic tree with many branches. Crit Rev Biochem Mol Biol 1990;25:307-384.
10. Roberts CW, Roberts F, Lyons RE, Kirisits MJ, Mui EJ, Finnerty J, Johnson JJ, Ferguson DJ, Coggins JR, Krell T, Coombs GH, Milhous WK, Kyle DE, Tzipori S, Barnwell J, Dame JB, Carlton J, McLeod R. The shikimate pathway and its branches in apicomplexan parasites. J Infect Dis 2002;185:S25-S36.
11. Haslam E. Shikimic acid: metabolism and metabolites. Chichester, United Kingdom: Wiley; 1993.
12. Ratledge C. Nutrition, growth and metabolism. In: Ratledge C, Stanford JL, editors. The biology of the Mycobacteria, Vol. 1. London: Academic Press; 1982. pp 185-271.
13. Parish T, Stoker NG. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 2002;148:3069-3077.
14. Michel G, Roszak AW, Sauve V, Maclean J, Matte A, Coggins JR, Cygler M, Lapthorn AJ. Structures of shikimate dehydrogenase AroE and its Paralog YdiB. A common structural framework for different activities. J Biol Chem 2003;278:19463-19472.
15. Padyana AK, Burley SK. Crystal structure of shikimate 5-dehydrogenase (Sdh) bound to Nadp: insights into function and evolution. Structure 2003;11:1005-10013.
16. Ye S, Von Delft F, Brooun A, Knuth MW, Swanson RV, McRee DE. The crystal structure of shikimate dehydrogenase (AroE) reveals a unique NADPH binding mode. J Bacteriol 2003;185:4144-4151.
17. Han C, Wang L, Yu K, Chen L, Hu L, Chen K, Jiang H, Shen X. Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori. FEBS J 2006;273:4682-4692.
18. Magalhães MLB, Pereira CP, Basso LA, Santos DS, Cloning and expression of functional shikimate dehydrogenase (EC 1.1.1.25) from Mycobacterium tuberculosis H37Rv. Protein Expr Purif 2002;26:59-64.
19. Fonseca IO, Magalhães ML, Oliveira JS, Silva RG, Mendes MA, Palma MS, Santos DS, Basso LA. Functional shikimate dehydrogenase from Mycobacterium tuberculosis H37Rv: purification and characterization. Protein Expr Purif 2006;46:429-437.
20. Fonseca IO, Silva RG, Fernandes CL, Souza ON, Basso LA, Santos DS. Kinetic and chemical mechanisms of shikimate dehydrogenase from Mycobacterium tuberculosis. Arch Biochem Biophys 2007;457:123-133.
21. Pace CN, Vajdos F, Fee L, Grimsley G, Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 1995;4:2411-2423.
22. Böhm G, Muhr R, Jaenicke R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng 1992;5:191-195.
23. Borges JC, Pereira JH, Oliveira JS, Santos GC, Olivieri JR, Ramos CHI, Palma MS, Basso LA, Santos DS, de Azevedo WF, Jr. Phosphate induces conformational changes in 5-enol-pyruvylshikimate-3-phosphate synthase from Mycobacterium tuberculosis. Arch Biochem Biophys 2006;452:156-164.
24. Schaffer AA, Aravind L, Madden TL, Shavirin S, Spouge JL, Wolf YI, Koonin EV, Altschul SF. Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 2001;29:2994-3005.
25. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.
26. Berman HM, Westbrook I, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000;28:235-242.
27. De Azevedo WF. Targets for development of drugs against orphan diseases. Curr Drug Targets 2007;8:387-387.
28. Ducati RG, Basso LA, Santos DS. Mycobacterial shikimate pathway enzymes as targets for drug design. Curr Drug Targets 2007;8:424-435.
29. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
30. Clamp M, Cuff J, Searle SM, Barton GJ. The Jalview Java alignment editor. Bioinformatics 2004;20:426-427.
31. Cuff JA, Barton GJ. Application of multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins 2000;40:502-511.
32. Kroemer RT, Doughty SW, Robinson AJ, Richards WG. Predition of the three-dimensional structure of human interleukin-7 by homology modeling. Protein Eng 1996;9:493-498.
33. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779-815.
34. Sali A, Overington JP. Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci 1994;3:1582-1596.
35. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M. Evaluation of comparative protein modeling by MODELLER. Proteins 1995;23:318-326.
36. Sali A. Modeling mutations and homologous proteins. Curr Opin Biotechnol 1995;6:437-451.
37. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: a program for macromolecular energy minimization and dynamics calculations. J Comput Chem 1993;4:187-217.
38. Ritchie DW. High order analytic translation matrix elements for real space six-dimensional polar fourier correlations. J Appl Crystallogr 2005;38:808-818.
39. Braun W, Go N. Calculation of protein conformations by proton-proton distance constraints. A new efficient algorithm. J Mol Biol 1986;186:611-626.
40. Uchôa HB, Jorge GE, da Silveira NJ, Câmera JC, Canduri F, De Azevedo WF. Parmodel: a web server for automated comparative modeling of proteins. Biochem Biophys Res Commun 2004;325:1481-1486.
41. Laskowski RA, MacArthur MW, Smith DK, Jones DT, Hutchinson EG, Morris AL, Naylor D, Moss DS, Thornton JM. PROCHECK v. 3.0 - program to check the stereochemistry quality of protein structures - operating instructions. 1994.
42. Brünger AT. X-PLOR Version 3.1: a system for crystallography and NMR. New Haven, CT: Yale University Press; 1992.
43. Collaborative Computational Project No. 4. The CCP4 suite: programs for proteins crystallography. Acta Crystallogr D Biol Crystallogr 1994;50:760-763.
44. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. The Xplor-NIH NMR molecular structure determination package. J Magn Res 2003;160:66-74.
45. Bowie JU, Luthy R, Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science 1991;253:164-170.
46. Luthy R, Bowie J, Eisenberg D, Assessment of protein models with three-dimensional profiles. Nature 1992;356:83-85.
47. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983;22:2577-2637.
48. García de la Torre J, Huertas ML, Carrasco B. Calculation of hydrodynamic properties of globular proteins from their atomic-level structure. Biophys J 2000;78:719-730.
49. Zhang X, Zhang S, Hao F, Lai X, Yu H, Huang Y, Wang H. Expression, purification and properties of shikimate dehydrogenase from Mycobacterium tuberculosis. J Biochem Mol Biol 2005;38:624-631.
50. Vogan E. Shikimate dehydrogenase structure reveals novel fold. Structure 2003;11:902-903.
51. Jones S, Thornton JM. Principles of protein-protein interactions derived from structural studies. Proc Natl Acad Sci USA 1996;93:13-20.
52. Herman KM, Weaver LM. The shikimate pathway. Annu Rev Plant Mol Biol 1999;50:473-503.